-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB Biotherapeutics Plans Participation in Four Investor Conferences

PUBT·11/09/2026 13:32:29
Listen to the news
SAB Biotherapeutics Plans Participation in Four Investor Conferences
  • SAB Biotherapeutics will attend four investor conferences; CEO Samuel J. Reich will lead fireside chats at three events.
  • Jefferies Global Healthcare Conference fireside chat: November 16, 2026, at 1:00 p.m. GMT in London.
  • UBS Global Biopharma Conference fireside chat: November 17, 2026, at 8:40 a.m. GMT in London.
  • 9th Annual Evercore Healthcare Conference fireside chat: December 1, 2026, at 2:35 p.m. EST in Coral Gables, Florida.
  • Citi Global Healthcare Conference one-on-one meetings: December 2, 2026, in Miami.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SAB Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611090830PRIMZONEFULLFEED9869953) on November 09, 2026, and is solely responsible for the information contained therein.